NDC 70000-0263-01 - LEADER CHILDRENS IBUPROFEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0263
- Requested NDC
- 70000-0263-01
- Package NDCs from labels
- 70000-0263-1, 70000-0263-2, 70000-0263-3, 70000-0263-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-03-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEADER CHILDRENS IBUPROFEN - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-03-03 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-1 | LEADER CHILDRENS IBUPROFEN | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 70000-0263-2 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 150 mL in 1 BOTTLE | SUSPENSION | 150 | 5 | |
| 70000-0263-3 | LEADER CHILDRENS IBUPROFEN | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0263 | LEADER CHILDRENS IBUPROFEN (IBUPROFEN) SUSPENSION [CARDINAL HEALTH 110, LLC. DBA LEADER] | 5 | Current NDC, Legacy NDC, 6 package rows | 20250305_913a4bd0-0784-45b4-b05e-3e7c016bbb86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0263-1 | ML - Milliliter | 70000-0263 | fbb179f2-5d83-4b39-a4c8-7f816a8d06e2 | 1 | 2017-11-06 |
| 70000-0263-2 | ML - Milliliter | 70000-0263 | fbe88e6f-ef78-4794-b3b0-585c7211eea8 | 1 | 2017-11-06 |
| 70000-0263-3 | ML - Milliliter | 70000-0263 | 5146b58d-9db9-4309-b673-3ed748b15b86 | 1 | 2018-03-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | L.N.K. International, Inc. | 8b5eec38-bdf3-4f27-802f-f4c732ae5c7d | 2026-02-02 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | H E B | 88c7486b-f9a7-4856-a25a-7c06e1382f1a | 2026-02-02 | Warnings | WK2XYI10QM |
| Regener-Eyes Ophthalmic Solution LITE XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 47ab9609-4291-30b2-e063-6394a90a421e | 2026-01-29 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, L.L.C. | 48d6dc98-66e8-b499-e063-6394a90ae935 | 2026-01-29 | Warnings | PDC6A3C0OX |
| Ibuprofen | IBUPROFEN | Strategic Sourcing Services, LLC | dc469eb2-89cc-46c9-9304-f6cf119c0570 | 2026-01-29 | Warnings | WK2XYI10QM |
| Caldolor | IBUPROFEN | Cumberland Pharmaceuticals Inc. | 1eaa7790-f1a1-4f51-b10a-cbbaf033f684 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | XF417D3PSL |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| IBUPROFEN 200 MG | IBUPROFEN 200 MG | Farmacias De Similares TX LLC | 441f7920-5666-5a3e-e063-6294a90a5583 | 2026-01-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Softgel Healthcare Private Limited | 2b07ace6-6766-0a06-e063-6294a90ad1bd | 2026-01-27 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Major Pharmaceuticals | 847758ed-66fc-4db9-8fdb-78f3c3291a03 | 2026-01-26 | Warnings | ANDA074937 197803 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CVS Pharmacy | 8d9f11a5-ca98-4280-9c6a-093d32e60ace | 2026-01-22 | Warnings | WK2XYI10QM |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| equate ibuprofen | IBUPROFEN | Wal-Mart Stores Inc | b29034a6-657b-426f-a41a-5e64c4bc759d | 2026-01-20 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | 70e191ef-8fad-49eb-9850-fceea119e92f | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Preferred Pharmaceuticals Inc. | b84ea215-e61d-4c00-8a34-d47c4080779b | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Lemon Glycerin | GLYCERIN | Jianerkang Medical Co., Ltd | edee14da-13d8-4bc2-9c37-cfc353763d11 | 2026-01-16 | Warnings | PDC6A3C0OX |
| Hemorrhoidal Cream | HEMORRHOIDAL CREAM | Walgreens | 1ac2b2ae-c090-483b-ad2c-1374552add4a | 2026-01-15 | Warnings | PDC6A3C0OX |
| Walgreens Adult Glycerin Laxative | GLYCERIN SUPPOSITORY | Walgreens | f19c6cca-e763-4c38-a546-855f027d20c5 | 2026-01-15 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.